INS and metabolic dysfunction-associated steatotic liver disease: We conclude that treating NAFLD with VLCKD is both beneficial and safe, which is possibly thanks to the simultaneous effects of different factors, such as the reduction of insulin levels, insulin resistance, body weight and fat mass, and the induction of ketosis.